LMLN and visceral leishmaniasis: Recently, it has been documented that low serum cholesterol in mice with visceral leishmaniasis is associated with downregulation of miR‐122 through the degradation of its processor, Dicer1, by the metalloprotease gp63, which inhibits cholesterol biosynthesis in infected mouse liver (Ghosh et al., 2013).